Lv1
4 积分 2024-09-22 加入
Has Antifungal Susceptibility Testing Come of Age?
1个月前
已完结
Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With E coli or Klebsiella pneumoniae Bloodstream Infection and Ceftriaxone Resistance
1个月前
已完结
Infectious Diseases Society of America 2024 Guidance on the Treatment of Antimicrobial-Resistant Gram-Negative Infections
1个月前
已完结
Unraveling ESBL and AmpC resistance in multi-drug resistant Klebsiella pneumoniae: phenotypic and genotypic insights
1个月前
已完结
Clostridioides difficile pathogenesis and control
1个月前
已关闭
Management of Sepsis in Hospitalized Patients
1个月前
已完结
Antibiotic therapy for severe bacterial infections
1个月前
已完结
Carbapenem-resistant Enterobacterales acquisition following piperacillin-tazobactam vs. meropenem treatment: a propensity-matched cohort study
1个月前
已完结
Piperacillin/tazobactam vs. cefepime or carbapenems for the treatment of bloodstream infections due to bacteria producing chromosomal AmpC beta-lactamase: a systematic review and meta-analysis
1个月前
已完结
Physicians’ perspectives on antimicrobial resistance and rational antibiotic prescribing
1个月前
已完结
皖公网安备34019202002308
